Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winfried Brenner

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Nuklearmedizin. Nuclear Medicine|February 20, 2020
Relationship of Renal Function in Mice to Strain, Sex and 177Lutetium-Somatostatin Receptor Ligand TreatmentAjay-Mohan Mohan, Mathias Lukas, Jakob Albrecht, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2011
Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumoursNils F Schreiter, Winfried Brenner, Munenobu Nogami, et al.
Nuclear Medicine Communications|December 1, 2007
Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1Ralph Buchert, Daniel von Borczyskowski, Florian Wilke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2004
CT-guided lymphoscintigraphy in patients with squamous cell carcinoma of the head and neck: a feasibility studyClaus Muhle, Winfried Brenner, Martin Südmeyer, et al.
Radiology and Oncology|December 2, 2014
Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CTNils Friedemann Schreiter, Ann-Mirja Bartels, Vera Froeling, et al.
European Radiology|June 27, 2014
Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancerIvayla Apostolova, Ingo G Steffen, Florian Wedel, et al.
Journal of Neuro-Oncology|April 27, 2021
High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entityKatja Bender, Eilís Perez, Mihaela Chirica, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2020
Multimodal Imaging of 2-Cycle PRRT with <sup>177</sup>Lu-DOTA-JR11 and <sup>177</sup>Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse ModelJakob Albrecht, Samantha Exner, Carsten Grötzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2025
[<sup>18</sup>F]FDG PET/CT for treatment monitoring and prediction of progression in retroperitoneal fibrosisChristian Bayerl, Jonas Kaufmann, Giulia Metzger, et al.
Annals of Nuclear Medicine|July 11, 2014
Optimized separation of left and right liver lobe in dynamic (99m)Tc-mebrofenin hepatobiliary scintigraphy using a hybrid SPECT-CT scannerDominik Geisel, Lutz Lüdemann, Bernhard Gebauer, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Nuklearmedizin. Nuclear Medicine|February 20, 2020
Relationship of Renal Function in Mice to Strain, Sex and 177Lutetium-Somatostatin Receptor Ligand TreatmentAjay-Mohan Mohan, Mathias Lukas, Jakob Albrecht, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2011
Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumoursNils F Schreiter, Winfried Brenner, Munenobu Nogami, et al.
Nuclear Medicine Communications|December 1, 2007
Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1Ralph Buchert, Daniel von Borczyskowski, Florian Wilke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2004
CT-guided lymphoscintigraphy in patients with squamous cell carcinoma of the head and neck: a feasibility studyClaus Muhle, Winfried Brenner, Martin Südmeyer, et al.
Radiology and Oncology|December 2, 2014
Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CTNils Friedemann Schreiter, Ann-Mirja Bartels, Vera Froeling, et al.
European Radiology|June 27, 2014
Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancerIvayla Apostolova, Ingo G Steffen, Florian Wedel, et al.
Journal of Neuro-Oncology|April 27, 2021
High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entityKatja Bender, Eilís Perez, Mihaela Chirica, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2020
Multimodal Imaging of 2-Cycle PRRT with <sup>177</sup>Lu-DOTA-JR11 and <sup>177</sup>Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse ModelJakob Albrecht, Samantha Exner, Carsten Grötzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2025
[<sup>18</sup>F]FDG PET/CT for treatment monitoring and prediction of progression in retroperitoneal fibrosisChristian Bayerl, Jonas Kaufmann, Giulia Metzger, et al.
Annals of Nuclear Medicine|July 11, 2014
Optimized separation of left and right liver lobe in dynamic (99m)Tc-mebrofenin hepatobiliary scintigraphy using a hybrid SPECT-CT scannerDominik Geisel, Lutz Lüdemann, Bernhard Gebauer, et al.
Pageof 17